October webinar – What are researchers thinking?

Would you like to hear what researchers and doctors were discussing at the recent International Conference on Lyme Borreliosis and Other Tick-Borne Diseases (ICLB 2022)? Join our webinar on October 20th and hear the inside news. We funded Lucy Delaney, a UK Research Fellow,  to travel to Amsterdam and at this webinar we shall be […]

more...

A marathon’s not just a run!

On Sunday October 2nd 2022 our runner in this year’s London Marathon will set off on her 26.2 miles. But in the lead up to this, Alice has done some tremendous work and it hasn’t all been pounding the pavements in training! Right from the beginning she has had to persuade people to donate to us […]

more...

Did you “recover”?

When, as a patient, you had treatment for Lyme disease, what was the outcome of that treatment? Did you completely recover and return to your normal health or did you still feel unwell in some way? As a GP, when you read the result of a trial of treatment for Lyme disease and it says […]

more...

ICLB – anything new?

The 16th International Conference on Lyme Borreliosis and Other Tick-borne Diseases starts today in Amsterdam and we have funded someone to go on our behalf and report back. No-one from LDA was free to attend, though we have attended many international conferences in the past, often being the only UK representatives. Time to get UK […]

more...

Support our fundraisers!

Through COVID lockdowns we have been working with researchers to try to move some of our projects forward, but we have no time to launch fundraising events ourselves. We are supremely grateful to those who do this job for us and spend time and energy training and then cycling or running. They take part in […]

more...

News on a Lyme disease vaccine

Can we prevent Lyme disease? A vaccine for Lyme disease has now progressed to a large human trial. Valneva’s VLA15 vaccine, in joint development with Pfizer, is designed to be effective against all strains of Borrelia, so the trial will include 6,000 people from both Europe and the USA. Read Valneva’s announcment. Small trials of […]

more...

COVID-19 v Lyme disease

You’ve been outside in your garden, or neighbouring park or countryside, perhaps spending a lunch break sitting on the grass. You don’t feel at all well. You think of COVID-19, and check the NHS website. Not conclusive. What else might it be? Try to avoid contact with others, as recommended, but if it doesn’t go […]

more...

Lessons to learn

Here is a very interesting case study amongst those recently added to our reference library. A young boy in Ukraine had a tick bite and was treated with doxycycline for 4 days “to prevent development of Lyme borreliosis”. 3 months later he had arthritis in one knee, but he had recently fallen so that was […]

more...

A new antibiotic?

A new antibiotic, found in soil, may be useful in treatment of Lyme disease, though more research is needed. Several interesting points came out of the recently published paper. Does this work in humans, as it seems to work in mice? Will it leave a patient’s beneficial gut bacteria untouched? Does protection of the gut […]

more...

Our first webinar

We have taken the decision to move into the Webinar Age, rather than just sending you another newsletter. This way you can hear directly from us and from others who are doing the work on which our Lyme disease progress (such as it is) depends. Our first webinar is to give you an update on […]

more...